- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 39-53 of
368 results
7 Institution Decision: Trial Instituted Document
Document
IPR2020-01252, No. 7 Institution Decision - Trial Instituted Document (P.T.A.B. Dec. 4, 2020)
|
|
Cite Document
No. 68
Document
Novo Nordisk Inc. et al v. Teva Pharmaceuticals USA, Inc., 1:17-cv-00227, No. 68 (D.Del. Aug. 8, 2018)
|
|
Cite Document
6 Notice of Filing Date Accorded to Petition: Notice of Accord Filing Date
Document
IPR2020-01252, No. 6 Notice of Filing Date Accorded to Petition - Notice of Accord Filing Date (P.T.A.B. Aug. 21, 2020)
|
|
Cite Document
No. 61
Document
Novo Nordisk Inc. et al v. Teva Pharmaceuticals USA, Inc., 1:17-cv-00227, No. 61 (D.Del. Jun. 26, 2018)
|
|
Cite Document
No. 23-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 23-1 (N.D.W.Va. May. 9, 2022)
|
|
Cite Document
No. 12-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 12-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 10-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 10-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 9-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 9-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 11-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 11-1 (N.D.W.Va. Mar. 28, 2022)
|
|
Cite Document
No. 2-6
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-6 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-7
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-7 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-19
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-19 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-17
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-17 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-13
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-13 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
No. 2-3
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 2-3 (N.D.W.Va. Mar. 18, 2022)
|
|
Cite Document
